walsuronoid B

structure in first source

Networked: 1 relevant articles (0 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 10/15/2017 - "In this study, we demonstrated for the first time that walsuronoid B inhibited cell proliferation in several human cancer lines. " 10/15/2017 - "Finally, walsuronoid B suppressed tumor growth in vivo with few side effects. "
2.	Liver Neoplasms (Liver Cancer) 10/15/2017 - "In summary, our findings demonstrated that walsuronoid B caused G2/M phase arrest and induced mitochondrial and lysosomal apoptosis through the ROS/p53 signaling pathway in human liver cancer cells in vitro and in vivo." 10/15/2017 - "Liver cancer cells (HepG2 and Bel-7402) were chosen for their high sensitivity to walsuronoid B. " 10/15/2017 - "Walsuronoid B induces mitochondrial and lysosomal dysfunction leading to apoptotic rather than autophagic cell death via ROS/p53 signaling pathways in liver cancer."